Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Class A Ordinary Shares, $0.0109 par value per share
-
Shares outstanding
-
433M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
2.61M
-
Shares change
-
-97.1K
-
Total reported value, excl. options
-
$2.3M
-
Value change
-
-$110K
-
Number of buys
-
8
-
Number of sells
-
-8
-
Price
-
$0.88
Significant Holders of TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0109 par value per share (TRIB) as of Q4 2024
29 filings reported holding TRIB - TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0109 par value per share as of Q4 2024.
TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0109 par value per share (TRIB) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.61M shares
of 433M outstanding shares and own 0.6% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (1.79M shares), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (379K shares), RENAISSANCE TECHNOLOGIES LLC (189K shares), Whitefort Capital Management, LP (81.9K shares), RAYMOND JAMES FINANCIAL INC (26.4K shares), Moss Adams Wealth Advisors LLC (25.7K shares), Cambridge Investment Research Advisors, Inc. (22.3K shares), BECKER CAPITAL MANAGEMENT INC (18K shares), GEODE CAPITAL MANAGEMENT, LLC (17.7K shares), and GAMMA Investing LLC (13.3K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.